Udit Batra
New CEO Udit Batra, with over two decades in pharma and life sciences, is expected to drive 22-24% earnings growth through strategic investments and small acquisitions.
Former colleagues unanimously praise Batra's sharp analytical mind and leadership, believing he will successfully lead the company into its next growth phase.
Batra's track record includes successful turnarounds at Millipore and Novartis, and his familiarity with Waters' customer base positions him well for his new role.
By submitting this form, you are agreeing to ManagementTrack’s Privacy Policy. You can choose to opt out of marketing or advertising emails using the ‘unsubscibe’ link included in our emails.
The best
The best
The best
Our investigative journalists interview the top former colleagues of the CEOs you care about.
Our former buysider analysts summarize the key strengths & weaknesses, past successes & failures, and ability to drive value going forward.
You get access to the actual anonymized transcripts and insights.